Brimofine Eye Drop
By Brimofine
Rx
5ml Ophthalmic Solution in a Packet

Composition
Brimonidine(0.15% w/v)

Manufacturer - Calix Health Care
35 B, Royal Hill, Near NNP I & II, Goregaon East, Mumbai - 400 065.

Expires on or after
September, 2025

liver
When using Brimofine Eye Drop, it is important to take caution regarding liver issues. There is no established interaction known at this time between the eye drop and liver function. It is advisable to monitor your liver health while using Brimofine Eye Drop. If you have any concerns or experience any adverse effects related to your liver, consult your healthcare provider immediately for further guidance.

kidney
No interaction or safety advice related to kidney issues has been found for Brimofine Eye Drop. Consult with your doctor for proper guidance before use.

alcohol
No interaction between alcohol and Brimofine Eye Drop has been established. It is advised to consult your doctor if you are pregnant.

driving
Caution should be exercised when using Brimofine Eye Drop as it may cause blurred or abnormal vision, especially in low light conditions. This can affect your ability to drive safely.

pregnancy
Brimofine Eye Drop is generally safe to use during pregnancy based on animal studies. Limited human studies are available regarding its effects on pregnancy.

breastfeeding
It is advised to exercise caution while using Brimofine Eye Drop during breastfeeding. Limited data indicates minimal risk to the baby. To minimize transfer through breastmilk, apply pressure on the eye corner and remove excess solution with a tissue.
Habit Forming | No |
Chemical Class | Quinoxaline Derivative |
Therapeutic Class | - |
Action Class | Sympathomimetics- Ocular |
₹114.28
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025